Abstract. For medical device organisations to market their devices in specific geographic regions they must adhere to the regulations of that region. These regulations often recommend that organisations adhere to specific standards and guidance documents which specify "what" must be achieved without specifying "how" this may be done. Due to changes to the medical device directive, which governs the development of medical devices within the EU, in March 2010, software can now in its own right be considered a medical device. This change has meant that a number of software organisations developing software for the medical device domain must now adhere to the same regulations as other medical device manufacturers. In this work we present a concept for a Software Process Improvement (SPI) roadmap to guide such organisations through the task of implementing medical device standards and guidance documents. In addition we present and evaluate a methodology that can be used to create a SPI roadmap from a set of requirements such as the aforementioned standards and guidance documents.
Introduction
Technological advancements are increasing the level of care that is being afforded to patients by their physicians. These advancements are becoming increasingly dependent on the use of software, as software can be easily used to configure a medical device without the need for expensive and time consuming hardware changes [1] . In 2006, Faris et al. [2] estimated that approximately half of all medical devices on the US market contained software. In order to achieve the benefits outlined above, the complexity of software has been increased dramatically, posing higher risks of software malfunction and miss-application. Between 2005 and 2009, 87 models of infusion pumps were recalled due to safety problems [3] . A whitepaper on the use of infusion pumps produced by the FDA in response to this, reports that "many of the problems that have been reported are related to software defects". Although this is only one example, recent trends show that an increasing number of medical devices are being recalled due to software failures. Due to the increasingly important role of software in these devices, software is now included in the EU's definition of a medical device [4] subjecting it to the same processes and standards as other medical devices. This has resulted in a number of software products being reclassified as a medical device. This reclassification has meant that organisations producing these products must now adhere to the same regulations as other medical device organisations. To ensure compliance, organisations like these are facing the challenge of implementing a number of medical device standards and guidance documents. These standards and guidance documents clearly define what must be achieved without providing specific methods for achieving them [5] . In this work we aim to alleviate this problem through the use of a series of software process improvement roadmaps. These roadmaps will not only outline what an organisation must do and when it should be introduced (in line with the software development lifecycle), but will also provide specific guidance on the best way to achieve these requirements for individual organisations. Previous work by the authors [6] has outlined the structure of these roadmaps and proposed a methodology for their development. In this paper we aim to re-evaluate this methodology in light of its application to two medical device standards, IEC 62366 [7] and ISO 14971 [8] , and to share our experiences in the application of the methodology to allow future researchers learn from these experiences. The remainder of this paper is structured as follows: Section 2 outlines the background to this work and discusses the importance of software to the medical device domain. Section 3 examines the role of software processes and software process improvement within the medical device domain. In section 4 we describe the structure of the roadmaps and a methodology for their development. Section 5 then discusses how the roadmap development methodology was applied to two international standards and discusses the impact this will have on the methodology in the future. Section 6 then concludes the paper with an outline of how this work will progress.
Notwithstanding the lack of guidance, there are a number of commonly accepted best practices which can direct practitioners with the implementation and maintenance of traceability. In section 2 of this paper we present twenty three best practices which we have identified from literature [8, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . In section 3, we discuss our findings from interviewing two small to medium sized (SME) medical device companies about their application of these best practices. We then analyse our findings in section 4 before providing our conclusions in section 5.
Related Work

Medical Device Regulations, Standards and Guidance Documents
In order to sell a medical device within the European Union (EU), the medical device organisation must demonstrate that they are compliant with the regulations set forth by the EU. Similarly, to sell medical devices within the US the organisation must demonstrate compliance with the FDA regulations [9] . In order to help organisations achieve compliance with these regulations, the EU and FDA have published standards and guidance documents that address specific aspects of the regulations and also recommend compliance with harmonised and consensus international standards, such as IEC 62304 [12] and ISO 13485 [10] . Medical device organisations may chose not to follow these standards and guidance documents and still receive approval to market their device; however they must provide strong justification for not doing so.
To achieve regulatory compliance one of the most fundamental requirements of a medical device development organisation is the implementation of a Quality Management System (QMS). A QMS ensures that the processes used during the development and production of a medical device are defined and monitored to ensure high quality products are developed. The requirements of a QMS have been outlined by the International Organisation for Standardization (ISO) in ISO 13485:2003 [10] . This standard is referred to by the European regulations and has recently been accepted by the FDA as adequate fulfilment of the requirements of a QMS.
As part of the QMS, organisations must perform risk management activities. To improve the quality of the medical devices, the organisation should identify all risks possible and take appropriate action to help mitigate these risks. ISO 14971:2007 [8] describes the requirements of a risk management process for medical device development. This standard identifies 6 key stages of a risk management; risk analysis, risk evaluation, risk control, evaluation of overall residual risk acceptability, risk management report, and production and post-production information.
During the development of a medical device, it is important to consider how the user will interact with it. Usability (the extent to which a product can be used by specified users to achieve specified goals with effectiveness, efficiency and satisfaction in a specified context of use [11] ) can be a source of great risk. The IEC 62366 [7] standard defines a usability engineering process that can help medical device developers produce usable products thereby reducing the risk of use errors. The standard is strongly focused on risk reduction and is therefore closely related to the ISO 14971 standard.
IEC 62304:2006 -Medical device software -Software life cycle processes [12] provides specific guidance on how to perform software development activities for software that is to be incorporated in a medical device. This is an EU harmonised standard and is recognised by the FDA as a consensus standard. It is therefore used to develop medical device software for both the European and US markets.
Software Process and Improvement
Software process improvement aims to analyse existing software development processes with a view to continually improve these processes through a series of additional refined practices. This approach has provided many benefits to organisations undertaking software process improvement initiatives including higher quality software, improved productivity and reduced time to market [13] [14] [15] [16] [17] [18] [19] .
The Software Engineering Institute has set out a roadmap for the undertaking of a software process improvement initiative [20] . This report identifies three main phases in which the software process improvement initiative should progress through. The first phase is to initiate the process improvement initiative which involves learning about SPI, committing initial resources and building a process infrastructure. The next phase is to baseline the current state of the organisations software processes. This is achieved through the undertaking of a software process improvement assessment, such as ISO/IEC 15504-5:2012 [21] (SPICE) or Capability Maturity Model® Integration (CMMI®) [22] . During an assessment the organisations current processes are assessed and measured, and any weakness or shortcomings are identified. Both ISO/IEC 15504-5 and CMMI® contain capability levels which allow an organisation to quantify the current state of their processes. These levels also facilitate the setting of targets which the organisation can reach through its process improvement initiative.The final phase of the software process improvement initiative is to implement or deploy the software process improvements. This stage involves the identification of suitable methods for improving the software processes by addressing the weakness and shortcomings identified during the assessment and then implementing them within the organisation.
Software process improvement is not an overnight activity. It takes long-term commitment from all employees of the organisation, especially senior management, who must provide adequate resources for the implementation of such an initiative [23] . In describing a usability maturity model developed by Nielsen, the Healthcare Information and Management Systems Society (HIMSS) usability task force noted that it can take decades to reach full maturity [24] .
Software Process Improvement within the Medical Device Domain
As regulatory bodies only outline the regulatory requirements which must be complied with and not how they can be effectively achieved, medical device organisations have been compliance centric in their approach to software development. As a result, there has been very limited adoption of software process improvement within the medical device domain [4] .
In addition existing generic SPI models, such as the CMMI® and ISO/IEC 15504-5:2012 (SPICE), do not provide sufficient coverage to achieve medical device regulatory compliance [25] . To address this issue a medical device specific SPI framework, titled Medi SPICE, is being developed [26] .
The objective of undertaking a Medi SPICE assessment is to determine the state of a medical device organisation's software processes and practices, in relation to regulatory requirements and best practices with the goal of identifying areas for undertaking process improvement [25] . It can also be used as part of the supplier selection process when an organisation wishes to outsource or offshore part or all of their medical device software development to a third party or remote division [27] . The Medi SPICE PRM consists of 44 processes and 15 subprocesses which are fundamental to the development of regulatory compliant medical device software. Each process has a clearly defined purpose and outcomes that must be accomplished to achieve that purpose.
Medi SPICE also contains a PAM which is related to the PRM and forms the basis for collecting evidence that may be used to provide a rating of process capability. This is achieved by the provision of a two-dimensional view of process capability. In one dimension, it describes a set of process specific practices that allow the achievement of the process outcomes and purpose, defined in the PRM; this is termed the process dimension. In the second dimension, the PAM describes capabilities that relate to the process capability levels and process attributes. This is termed the capability dimension [30] .
Software Process Improvement Roadmaps
In this work we propose the use of a software process improvement framework for the implementation of medical device standards. Unlike traditional SPI models, the goal of the roadmap implementation framework is not to improve existing processes but to implement the processes necessary to meet the requirements of a specific standard. Initially this work will focus on the development of SPI roadmaps for key medical device standards; IEC 62366, ISO 14971, ISO 13485 and IEC 62304.
In this section we outline the form of the SPI roadmaps and propose a structured procedure for their development. We then outline the benefits that can be afforded through the adoption of such a strategy. The section concludes with a description of how the roadmaps could be implemented within an organisation entering the medical device domain for the first time.
Roadmap Structure
To assist medical device software development organisations achieve compliance with the required standards, we propose the development of a set of software process improvement roadmaps. For the purposes of this work we define a roadmap as: A series of milestones, comprised of goals, that will guide an organisation, through the use of specific activities, towards compliance with regulatory standards.
The roadmap is divided into two levels. The first level defines the goals, grouped into milestones, that the organisation should achieve throughout the SPI initiative. The first level of the roadmap is presented at a high level and does not contain any detail relating to how the goals should be achieved. This is done for two reasons. Firstly, by presenting the roadmap as a series of goals traceability to the relevant standard can be easily achieved. Secondly, the high-level roadmap can form a basis for communication across the industry as the same high-level roadmap can be applied to all organisations.
The second level roadmap contains specific guidance for organisations on how to achieve the goals outlined in the high level roadmap. The method of achieving these goals can vary between organisations due to their nature, different abilities and resources. Therefore each roadmap is comprised of multiple activities that can achieve each goal so that the most suitable activity can be presented to an organisation wanting to implement the roadmap.
Roadmap Development Methodology
The following methodology is proposed to provide a systematic approach to roadmap construction. This systematic approach will allow for other researchers to construct roadmaps for other regulated domains, such as the automotive domain or the aerospace domain. The following approach is similar to the transformation method presented in [31] for the construction of ISO/IEC 15504-2 compliant process assessment and process reference models. The goal of the transformation methodology presented in [31] was to develop a process reference model and process assessment model. As the goal of this methodology is to develop a roadmap for implementing medical device standards it was necessary to alter the methodology to account for the order of implementation and the distinction between the goals and activities (or practices in ISO 15504) in the roadmap.
There are a range of research methods that can be used with the following methodology. These methods are used to validate the roadmap and to assist in the identification of a wide range of activities. By incorporating a wide range of activities, the generated roadmaps can provide more suitable guidance to implementing organisations.
The methodology used for the development of the roadmaps is as follows:
1. Identify requirements of the standard: The first step in the process of developing the roadmap is to identify all the requirements from the standard (Henceforth the requirements will be known as 'goals' to differentiate the roadmap from the standard). This step is similar to the first step in the transformation process presented in [31] and will be achieved through manual analysis of the standard.
2. Logically group all goals. The next step is to group the goals. Goals are grouped based on the stage of the software development lifecycle at which they occur. However some goals are performed throughout the lifecycle, independent of specific phases. In those cases these goals should be grouped together and placed at or before the first stage at which they are performed in the software development lifecycle.
4.
Order the milestones based on the capability level and logical groups. All milestones containing level 1 goals should be implemented first in the order in which they will occur in the development process, followed by all milestones containing level 2 goals, and subsequently by all milestones containing level 3 goals until all of the milestones are in order.
5. Validate generated roadmap. The generated roadmap should be validated with industry experts. These experts could be individuals working in industry implementing the standards, assessors regulating organisations using the standards or academics with the appropriate expertise. Members of the standards committee could also assist with the validation.
There are a number of methods that could be used to validate the roadmap. One approach could be to interview the experts after presenting the roadmap to them and providing sufficient time for them to review the material. Another approach could be a workshop in which the roadmap is presented to the experts and then a panel discussion is used to identify and rectify issues that may be present. A Delphi study could also be used.
A Delphi study involves multiple iterations and review by experts. In this case the experts are first asked to complete a questionnaire about the roadmap. Once the responses have been analysed, the roadmap is then revised and resubmitted to the experts for a subsequent review. This is repeated until a roadmap is agreed upon.
The validation should aim to ensure that:
• The goals are correctly grouped;
• The milestones are in the correct order for implementation; and 6. Identify activities that can meet the identified goals. The next step in the generation of the roadmap is to identify appropriate activities that can be used to fulfil the requirements of each goal in the roadmap. This can be done through a systematic literature review and/or case studies with organisations already implementing the standard.
7. Validate activities in host organisation. The final stage of the roadmap development methodology is to validate the roadmap within a host organisation. This will involve the generation of a roadmap for the host organisation and then undertaking a software process improvement initiative to implement the roadmap.
Benefits of the SPI Structured Roadmap
The approach outlined above was adopted for a number of reasons. Firstly by dividing the roadmap into a high level and a low level, traceability between the roadmap and its corresponding standard could be easily achieved. The high-level roadmap described in Section 4.1 outlines the key requirements that need to be implemented which can be easily traced back to the corresponding sections of the standard. This will allow manufacturers clearly see which sections of the standard have been implemented at each stage of the implementation.
The separation of high-level requirements from the low level implementation of these requirements allows the roadmap to be customised for a particular organisation while simultaneously still ensuring they are meeting the requirements of the standard. As multiple low-level activities can be used to meet the same requirements, organisations can choose the activity that best suits their organisation.
Application of the roadmap
The first stage in using the proposed roadmaps is to assess the organisations existing processes and to determine which goals they already meet. This can be done in a number of ways, including the use of existing process assessment models, such as Medi SPICE or assessment models developed from the standards through the transformation method presented in [31] .
The next stage is to identify which goals the organisation needs to implement in order to meet the requirements of the relevant standard and arrange in line with the high-level roadmap. As an organisation may already have a number of goals achieved from different high-level milestones, the remaining goals may be merged to provide a more efficient implementation process. Due to the traceability provided by the roadmap development methodology, it is easy for an organisation to see which aspects of the standard are not being met.
Once the goals to be implemented have been identified, the next step will be to identify the relevant activities that will satisfy these goals. The identification of the correct activities will be based not only on the goals to be achieved, but also on the organisation itself. Factors, such as the organisation's size, the class of medical device being developed, and the distribution of the software development team or teams, can all impact the way in which an organisation will implement the standard. For example a globally distributed organisation will not perform risk management meetings in the same way as a co-located organisation.
Once the appropriate activities have been identified for the organisation, they will begin to implement these activities. The roadmap defines specific milestones in a progressive order that will guide this implementation.
Evaluation
This section presents two case studies that have used the roadmap development methodology to develop and validate a high-level roadmap for two medical device standards. The first case study describes the development of a high-level roadmap for the IEC 62366 standard for usability engineering for medical devices while the second roadmap describes the development of a high-level roadmap for ISO 14971. A full description of the developed roadmaps is beyond the scope of this experience report on the application of the roadmap development methodology.
Validation Methodology
To validate each of the roadmaps an expert evaluation was used. There were two aims established for each validation: 1. To determine if the goals are appropriately grouped into milestones 2. To determine if the ordering of the milestones is appropriate for implementation in a medical device organisation. To meet these objectives, experienced personnel within each of the two domains, risk management and usability of medical devices, were approached via email to participate in the study. Each participant who agreed to take part was then asked to log in to an online evaluation tool and complete the evaluation questionnaire. The questionnaire, illustrated in Figure 1 , showed participants each milestone in turn and asked them to state whether they thought each goal belonged in the milestone it was included in. In addition the participants were asked to rate on a 5 point likert scale (where 1 = strongly disagree and 5 = strongly agree) whether they agreed with the following statement; The order of this milestone within the roadmap is correct. The participants were also provided with the opportunity to add any additional comments they felt were relevant.
Figure 1: Screenshot from online questionnaire
In addition to this, the online questionnaire also provides the user with the opportunity to state at what capability level, in line with 15504-2, each goal should be accomplished at. As the participants who took part in the study were experts in medical device standards and not software process improvement these results were not included in the study. However we did manage to recruit 1 software process improvement expert whose feedback is included. During the study participants could move freely through the roadmap using a navigation panel on the top of the screen as illustrated in Figure 2 . The navigation panel was colour coded to allow participants monitor their progress during the study:
 White indicated milestones the user had not yet completed,  Light green indicated the milestone they were currently on  Dark green indicated milestones for which they had completed the survey. 
Case Study 1-IEC 62366
The first case study conducted applied the roadmap development methodology to the IEC 62366 standard. This standard outlines the requirements for a usability engineering process and describes what needs to be done to minimise use related risks. The standard requires the development of a number of documents, including a usability engineering file which should at least reference all of the documentation relating to the usability engineering process.
Step 1 of the methodology identified 44 goals, that were separated into 10 milestones (step 3) that are implemented throughout the software development lifecycle. Table 1 shows the number of goals that were included in each of the milestones for the IEC 62366 roadmap. It can be seen that the number of goals range from 2 to 7 per milestone. Once the roadmap was produced it was validated by 5 participants with experience of usability engineering for medical devices. In total 18 individuals were contacted in relation to the validation however, only 5 agreed to participate in the study. Some individuals responded saying they did not have sufficient time while others did not respond at all. The validation was performed using the validation method described in Section 5.1
Overall the participants felt that the initial roadmap was well structured, however they did feel that the last two milestones should be implemented earlier. It was felt that the Process milestone should be the first milestone as it defines and maintains the overall process of usability engineering.
Although a full overview of the results is beyond the scope of this paper, it is important to mention that the results obtained in relation to the capability level of each goal provided little agreement among the participants. This result may be explained by the participants area of expertise being in the area of usability engineering and not in ISO 15504 capability levels.
As a result of the validation, the roadmap was revised to include only 39 goals (some of the original goals were merged where the documentation of an activity and the activity itself were separate goals) divided into 9 milestones. Two milestones, validation and validation management, were merged to form a single goal as these were originally separated based on their capability level. Table 2 shows the number of goals by milestone for the revised roadmap. 
Case Study 2 -Roadmap for ISO14971
The second case study applied the roadmap development methodology to the ISO 14971 standard. ISO 14971 describes the risk management process that should be applied during the development of medical devices. The standard itself is not limited to software but can apply to any type of medical device. The standard outlines a 6 phase risk management process ranging from risk analysis, which is the identification of possible risks posed by the medical device to Production and post-production management of any residual risks.
The roadmap generated by the roadmap development methodology contained 51 goals divided among 14 milestones. Table 3 shows that there are between 1 and 7 goals per milestone in the roadmap. As risk management is an on-going activity with each stage being repeated throughout the software development lifecycle, the roadmap should be used to introduce the goals early in the product lifecycle so that the necessary activities are in place when needed. As was found in case study 1, the validation of the roadmap found that a number of the milestones, which contained goals believed to be at capability level 2 (Managed process-the process meets the requirements for capability level 1 where the process is performed, and is now implemented in a managed fashion), were introduced too late in the roadmap and as such should be introduced earlier. In addition it was also found that in a number of cases the separation of an activity from its documentation was unnecessary and these goals should be grouped into a single goal.
The validation resulted in a number of changes to the roadmap. The resulting roadmap contains 44 goals divided among 14 milestones. Although the number of milestones did not change as a result of the validation the ordering of these milestones did. Three of the final 4 milestones were moved so that they would be implemented at the beginning of the implementation process. The final number of goals and order of the milestones can be seen in table 4 (read from top to bottom, then left to right). 
Discussion
The case studies described above have provided a lot of insight into the methodology and have highlighted a number of issues that can arise when applying it to medical device standards.
The first stage of the process is to determine the requirements of the standards. Although the standards are quite clear in what they require organisations to do, they contain a lot of supporting information which can be difficult to discern from the requirements. The authors judgement was used in determining this and the validation found that these judgements were correct. Additionally, it was found that the standards use consistent terminology to describe what needs to done in order to be in compliance with the standard. The consistency of the terminology makes it easier to determine, at a high-level, what needs to be done. This consistency could also allow for the use of NLP techniques to identify the requirements from the standard, the first step in the roadmap development process. Although this will be accurate in most cases, the user of such a tool should review the output to ensure that some supporting statements are not interpreted as requirements.
During the application of step 2 to the requirements it was identified that not all processes can adhere to the software development lifecycle. In the cases outlined above it was found that there were logical groupings that could be easily identified however, some requirements would not easily fit into these groupings. For example in case study 2 it can be seen that 2 of the milestones contained only a single goal.
Although the methodology itself can be quite flexible it was found in both case studies that dividing the goals based on their capability level provided little benefit as most of the goals should be implemented by a level 1 organisation. During case study 1 an ISO 15504-2 expert was asked to review the goals to determine if they were assigned an appropriate capability level. This expert remarked that as they are a requirement of the standard they should all be assigned a capability level of 1. For this reason it has been determined that this step (step 3) should be removed from the methodology.
In the cases outlined above it was found that the logical groupings provided a clear path to implementation. The use of the ISO 15504 capability levels in this step however, did cause problems. Some of the goals that were determined to be implemented at level 2 are necessary at the start of the implementation, for example the development of a standard operating procedure. Including these levels in the ordering of the milestones lead to the development of inaccurate roadmaps that was quickly identified by the experts.
The case studies also revealed that it is important to select the correct method for validation. In both cases an online form was used to collect the opinions of the validators on the roadmap. Although this approach provided sufficient validation for the two standards selected, this may not scale well due to the large number of inputs that would need to be completed. In case study 2 one participant opted to email their comments directly to the author instead of completing the online form. To address this issue future validation studies may instead opt to take on a different format. One possibility is the use of a workshop whereby the participants are co-located and presented with the roadmap and provided an opportunity to discuss the roadmap in much more detail.
During the case studies it was found that the separation of the documentation of an activity from the activity itself, as was done in a number of cases, should not be done. One of the validators remarked that "If it's not documented, it's not done", and suggested that the documentation of an activity should not be a separate goal but incorporated into the activity that is being performed.
Revised Roadmap Development Methodology
As a result of the validation the methodology now consists of:
1. Identify requirements of the standard: During this step it is important to ensure that requirements of the standard are identified and distinguished form supporting advice. These requirements should then be phrased as goals of the roadmap.
2. Logically group all goals. Careful consideration should be given to the groupings of the goals and it is advised that each group should not contain too many goals. If this is the case they may be separated into multiple sub-groups. The resulting groups will form the milestones for implementation.
3. Order the milestones based on the logical groups. The milestones should ordered in a way that is compatible with implementation in a software development process to ensure that organisations suffer limited disruption due to the implementation.
4.
Validate generated roadmap. The validation should be performed with industry experts and evaluate the roadmap to answer the following questions:
 Are the goals appropriately grouped into milestones?  Is the ordering of the milestones appropriate for implementation in a medical device organisation?
5. Identify activities that can meet the identified goals. Appropriate activities that can be used to fulfil the requirements of each goal in the roadmap should be identified. This may be done through a systematic literature review and/or case studies with organisations already implementing the standard.
Validate activities in host organisation.
The final stage of the roadmap development methodology is to validate the roadmap within a host organisation. This will involve the generation of a roadmap for the host organisation through collaboration between the organisation and industry experts and then undertaking a software process improvement initiative to implement the roadmap.
Limitations
The validation of the methodology is limited by the fact that validation of steps 5 and 6 has yet to be completed. Add a couple of sentence here
The validation described above did not include development of the activities repository or industry validation of a complete roadmap. For this reason the validation presented above is limited to the first 5 steps of the method-ology which can be used to develop a high-level roadmap. This in itself in a vital aspect to the development of software process improvement roadmaps.
The development methodology has been applied to two standards within the medical device domain. Before it can be established that the methodology can be applied as is to other domains, such as the automotive or aerospace domains, it must be validated within these domains.
Conclusions and future work
The implementation of any standard required in the development of medical devices can be a complex and time consuming issue. Medical device standards clearly outline what needs to be done but they do not provide specific guidance on how to do it. In this work we investigate how this problem can be addressed through the use of software process improvement roadmaps. SPI roadmaps provide specific activities, in-line with the medical device standards, for an organisation to implement the chosen standard in a way that complements existing software development lifecycle processes.
This paper outlines how such roadmaps can be developed through the use of the roadmap development methodology and report on the application of this methodology to two medical device standards, IEC 62366 and ISO 4971. In light of these case studies it was deemed that the methodology can be used to develop high level software process improvement roadmaps that would be well received by the medical device community.
In the future this work will examine the use of Natural Language Processing (NLP) techniques to assist in the development of such roadmaps, in line with the roadmap development methodology. NLP techniques could be used to automatically identify the requirements of a medical device standard, the first step in the presented methodology. This could greatly simplify the process of roadmap development as the identification of such requirements can be a time consuming task.
Using the roadmaps presented here, it is intended to recruit a number of medical device organisations to implement the roadmaps to evaluate how well the proposed roadmaps work in an industry setting. After an initial evaluation of the organisations existing processes, a customised roadmap will be developed for the organisation and they will be guided through its implementation, until they have met all of the requirements of the medical device standard
